| Source of record | UK Clinical Trials Gateway |
| ISRCTN | ISRCTN17844016 |
| Date ISRCTN assigned | 16/05/2007 |
| Local reference number(s) | N/A |
| Public title | DESMOND (Diabetes Education and Self Management for Ongoing and Newly Diagnosed): a randomised controlled trial of a structured group education programme for people newly diagnosed with type two diabetes |
| Scientific title |
|
| Acronym | DESMOND |
| Disease/condition/study domain | Self management of type two diabetes |
| Study hypothesis | To evaluate the effectiveness and feasibility of delivering structured group self-management education to individuals newly diagnosed with type two diabetes. |
| Design/methodology | Cluster randomised controlled trial |
| Research ethics review | Approval received from Multi-centre Research Ethics Committee (MREC) on the 16th June 2004. |
| Countries of trial | United Kingdom |
| Participants - inclusion criteria | 1. Greater than 18 years of age
2. Referred to the study within four weeks of diagnosis of type two diabetes
3. In intervention group, able to attend the intervention within 12 weeks of diagnosis |
| Participants - exclusion criteria | 1. Are unable to give informed consent
2. Have been recruited to take part, or are already taking part in other research
3. Have severe and enduring mental health problems
4. Are not primarily responsible for their own care
5. Are unable to participate in a group programme
6. Have insufficient understanding of English to participate in the group education |
| Patient information material |
|
| Anticipated start date | 01/07/2004 |
| Anticipated end date | 31/01/2007 |
| Status of trial | Completed |
| Target number of participants | 1,000 |
| Interventions | A programme of six hours of structured group education consisting of two three-hour sessions offered as either one day or two half-days, facilitated by two health care professionals trained to deliver the intervention to groups of up to ten people newly diagnosed with type two diabetes, who may be accompanied by a partner, family member or friend.
This is compared to a control group receiving enhanced routine care. |
| Primary outcome measure(s) | Glycaemic control as measured by HbA1c at 12 months. |
| Secondary outcome measure(s) | 1. Cardiovascular (CV) risk as measured by lipid profile and blood pressure
2. Quality of life indicators, diabetes control, self-care and illness belief perceptions of patients at 12 months |
| Publications | Results in http://www.ncbi.nlm.nih.gov/pubmed/18276664 |
| Sources of funding | 1. Diabetes UK (UK) (ref: BDA:RD04/0002922)
2. Department of Health (UK)
3. NovoNordisk (UK) - unrestricted educational grant |
| Sponsor name | University Hospitals of Leicester NHS Trust (UK) |
| Sponsor details | Gwendolen House
Gwendolen Road
Leicester
United Kingdom
LE5 4PW |
| Sponsor website | http://www.uhl-tr.nhs.uk/ |
| Contact name | Prof Melanie Davies |
| Contact details | Diabetes Research Team
Level 1 Victoria Building
Leicester Royal Infirmary
Leicester
United Kingdom
LE1 5WW |
| More information | For more up-to-date information please go to the ISRCTN link below. |
| Link to record in ISRCTN Register | ISRCTN17844016 |
| Date last extracted from ISRCTN register | 17/04/2008 |
